Taina E, Mäenpää J, Erkkola R, Kilkku P
Department of Obstetrics and Gynaecology, Satakunta Central Hospital, Pori, Finland.
Ann Chir Gynaecol Suppl. 1987;202:72-5.
A study was made to determine whether high dose-rate afterloaded Co60 (Cathetron) can be safely used in preoperative radiotherapy for patients with St. I-II cervical or endometrial cancer without an increase in surgical difficulties or postsurgical morbidity when compared with conventional radium therapy. Seventy-five patients with cervical cancer St. Ia-IIb were operated on radically two to three weeks after preoperative intracavitary radiotherapy of which 31 had been treated with the Cathetron and 44 with radium. Furthermore, 144 patients with endometrial cancer St. I-II were also operated on, of which 49 had received Cathetron and 95 radium treatment. No statistical differences were found between the two treatment groups in the duration of the operations, blood loss, or the frequency of early or late postoperative complications.
开展了一项研究,以确定高剂量率后装钴60(卡特龙)在术前放疗中用于I-II期宫颈癌或子宫内膜癌患者时,与传统镭疗相比,是否能安全使用,且不会增加手术难度或术后发病率。75例Ia-IIb期宫颈癌患者在术前腔内放疗后两到三周接受了根治性手术,其中31例接受了卡特龙治疗,44例接受了镭治疗。此外,144例I-II期子宫内膜癌患者也接受了手术,其中49例接受了卡特龙治疗,95例接受了镭治疗。两个治疗组在手术时间、失血量或术后早期或晚期并发症发生率方面均未发现统计学差异。